Manufacturing Job Creation Public Investment Government Funding International Business Dublin Development Clinical Trials U.S. Operations Research and Development Life Sciences Private Equity
The agreement establishes three research hubs, including an AI-focused center in London, and aims to deliver 10,000 personalized cancer vaccines by 2030.